Kansas tuberculosis outbreak is America's largest recorded since the 1950s
Outbreak scale & wording
- Several note the article’s key caveat: CDC TB monitoring only dates to the 1950s, so “largest in recorded history” really means “largest since CDC records began,” not larger than 19th‑century epidemics.
- Some argue the phrasing is misleading clickbait; others see it as imprecise but directionally correct and consistent with rising TB trends.
Tuberculosis biology, treatment, and resistance
- TB is treatable but requires long, harsh multidrug courses (often 6–9 months); adherence is difficult and incomplete treatment drives drug resistance.
- Multidrug‑resistant (MDR) and extensively drug‑resistant (XDR) TB are cited as serious concerns, especially given the slow pace of new drug development.
- TB survives inside macrophages and often becomes latent; many infected people never get sick, but latent infection can reactivate.
- There is disagreement on how “harsh” treatment is in practice; some report few side effects, others emphasize fear of noncompliance and toxicity.
Vaccination (BCG) and testing
- Non‑US commenters are surprised the article doesn’t mention the BCG vaccine, widely used elsewhere.
- US‑focused replies say BCG has long not been routine in the US due to:
- Doubts about its effectiveness in adults and variability by geography.
- Low overall US TB incidence.
- It interferes with traditional skin‑test screening, though newer blood tests avoid this.
- Some describe scars and local reactions from BCG and smallpox vaccines, and note the political difficulty of mass vaccination with visible side effects.
- A side debate questions long‑term evolutionary tradeoffs of vaccination vs “natural immunity”; others push back that this misreads TB data and ignores avoidable suffering.
Origins and epidemiology of the Kansas outbreak
- Linked earlier reports trace the cluster to four households in Kansas City, largely low‑income, with several adults born in a country that previously had an MDR‑TB outbreak with the same genotype.
- Likely route: importation via migration or travel plus latent infection, but exact chains are not fully public; some argue details are withheld to avoid scapegoating specific families or immigrants.
- TB remains relatively uncommon in the US but is not “gone,” with around 10k cases/year cited from CDC data within the thread.
CDC, MMWR, and US politics
- A major subthread claims CDC’s Morbidity and Mortality Weekly Report (MMWR) was abruptly paused by the new administration as part of an ideological purge, hindering outbreak communication.
- Others inspect MMWR archives and argue:
- MMWR is more like a scientific bulletin than a real‑time alert system.
- Kansas TB details had not appeared even before the change, so attributing their absence to politics may be inaccurate.
- Broader debate over Trump‑era and current federal decisions: cuts to public health teams, CDC staff in China, and polio campaigns are cited as contributors to COVID and other resurgences; opposing comments stress that COVID spread globally regardless.
- Meta‑discussion: some want less US political content on HN; others argue politics is inseparable from public health and technology funding.
Historical context, risk perception, and ethics
- Several note TB’s global resurgence; WHO data in the thread say TB has again become the top infectious killer worldwide.
- Others say TB has been hyped as a looming catastrophe since the 1980s and find it hard to calibrate urgency amid decades of alarm.
- Multiple anecdotes from people with latent TB or prior treatment illustrate:
- It can be asymptomatic and discovered via screening.
- Treatment may be tolerable but socially disruptive and long.
- Some argue TB control is a test of societal solidarity: it disproportionately affects poor and migrant populations and requires sustained investment that may not immediately benefit wealthier groups.
- Underlying theme: many modern publics have “forgotten” pre‑antibiotic and pre‑vaccine disease burdens, which fuels complacency and vaccine skepticism.